ERBB2 and neoplasm: Compared with the prediction success group, the prediction fail group exhibited older age, a higher FSH level, larger tumor size, higher grades, more LN metastasis, a higher PR negative rate, more HER2 expression, a higher Ki-67 level, and higher MGA risk (Table S3).